agilon health (AGL) to Release Earnings on Tuesday

agilon health (NYSE:AGL) is set to post its quarterly earnings results after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. agilon health has set its FY 2024 guidance at EPS.Parties that wish to listen to the company’s conference call can do so using this link.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Tuesday, February 27th. The company reported ($0.41) EPS for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.13). agilon health had a negative return on equity of 21.74% and a negative net margin of 5.76%. The firm had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same quarter last year, the business posted ($0.14) earnings per share. The firm’s revenue for the quarter was up 71.8% on a year-over-year basis. On average, analysts expect agilon health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

agilon health Trading Up 2.6 %

Shares of NYSE AGL opened at $5.13 on Tuesday. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.05. The stock’s 50 day moving average price is $5.51 and its two-hundred day moving average price is $9.29. agilon health has a 52-week low of $4.41 and a 52-week high of $26.75. The stock has a market capitalization of $2.11 billion, a P/E ratio of -7.89 and a beta of 0.49.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Wolfe Research downgraded agilon health from an “outperform” rating to a “peer perform” rating in a report on Monday, January 8th. Citigroup initiated coverage on shares of agilon health in a report on Monday, April 22nd. They set a “neutral” rating and a $6.00 target price on the stock. Royal Bank of Canada reduced their price target on shares of agilon health from $11.00 to $8.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 28th. Stifel Nicolaus lowered their price objective on shares of agilon health from $10.00 to $9.00 and set a “hold” rating for the company in a research report on Thursday, February 22nd. Finally, JPMorgan Chase & Co. lowered shares of agilon health from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $17.00 to $9.00 in a research note on Friday, January 5th. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $9.46.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.